StockLens

ALKEM vs BIOCON vs GRANULES vs NATCOPHARM: which stock is better?

Granules India Limited (GRANULES) has the highest StockLens rating in this group at 7.5/10 (Good).

MetricALKEMBIOCONGRANULESNATCOPHARM
Overall rating5.7/10 (Average)2.4/10 (Poor)7.5/10 (Good)6.2/10 (Average)
Long-term viewNeutral (watchlist)AvoidStrong long-term candidateNeutral (watchlist)
Trade biasStrong shortStrong shortStrong longStrong short
Share price₹5,175.00₹359.40₹815.50₹822.90
Market cap₹61,875 Cr₹58,861 Cr₹22,245 Cr₹16,143 Cr
P/E29.9120.628.517.9
Return on equity14.2%1.0%13.5%–
Debt / equity0.150.420.170.08
Revenue growth (YoY)+13.8%+2.2%+20.3%-44.7%
1-year return-8.7%-6.0%+47.0%+3.0%

Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.